| Literature DB >> 7719273 |
A Langlois-Karaga1, M Bues-Charbit, A Davignon, J Albanese, O Durbec, C Martin, N Morati, G Balansard.
Abstract
A double-blind randomized placebo-controlled study was carried out to evaluate the efficacy and the cost of selective digestive decontamination (SDD) to prevent nosocomial pneumonia in multiple-trauma patients. Nosocomial infections, particularly pneumonia, were more frequent in the placebo group. The most common infectious agent was Staphylococcus: Staphylococcus aureus in the placebo group and Staphylococcus epidermidis in the SDD group. Methicillin-resistant Staphylococcus epidermidis was detected more often in the SDD group. No methicillin-resistant Staphylococcus aureus was observed in this study. Fewer patients in the SDD group required antibiotherapy. SDD resulted in a saving of about 41% in drug expenditure.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7719273 DOI: 10.1007/bf01875552
Source DB: PubMed Journal: Pharm World Sci ISSN: 0928-1231